Just reported
From Resmed's results release of 29 octombrie 2026; its quarterly report has since been filed.
Actual
1,41B USD
+5,9 % y/y
-3,3 % q/q
Guided
—
No guide given
Actual
2,92 USD
+23 % y/y
+11 % q/q
Guided
—
No guide given
Actual
453M USD
+1,4 % y/y
+1,0 % q/q
Guided
—
No guide given
Full year 2027
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →The themes Resmed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Ponderile din venituri sunt estimări pentru quarter ended 2026-03-31, nu cifre dintr-un raport depus.
AirSense 11
A connected machine that delivers continuous or automatically adjusted air pressure to treat sleep apnea.
AirCurve 11
A bilevel breathing machine that provides different pressure levels for breathing in and out, for people needing more support or with complex breathing disorders.
Astral ventilators
Ventilators that provide breathing support, including for people receiving care at home.
AirTouch N30i, AirTouch F30i, and AirFit F40 masks
Masks that connect a person to a breathing machine during sleep; the named models include fabric and silicone designs.
myAir and AirView
Software for patients to engage with their sleep treatment and for providers to connect with and support patients.
Brightree and MEDIFOX DAN
Software products for residential care and home medical equipment providers.
Situațiile financiare complete →
ResMed makes devices that help people breathe during sleep and ventilators for people who need breathing support. It also sells masks and software for patients, medical equipment providers, and residential care providers. Its sleep products include machines that connect with patient and provider software.
Construit din raportările proprii ale Resmed Inc. la Comisia pentru Valori Mobiliare și Burse a SUA (SEC). Cifrele sunt cele raportate, iar istoricul pe acțiune este recalculat la baza de acțiuni de azi. Aceasta descrie o afacere — nu este consultanță de investiții și nu este o recomandare de cumpărare sau vânzare.
239,53 USD+0,2 %închidere 13 nov.
Cifre până la 30 septembrie 2026, din 10-Q depus pe 30 octombrie 2026
ResMed sells breathing machines and masks for sleep apnea and other breathing disorders to patients through medical equipment providers.
Grade B+
Banda de sub preț arată nota la fiecare dată, calculată doar din documentele publice până atunci.
Se afișează 2 din 41 trimestre din istoricul notelor companiei Resmed Inc.. Celelalte 39 merg înapoi până în octombrie 2016.